WTW Reports Fourth Quarter and Full Year 2024 Earnings

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Insights

WTW's Q4 2024 results showcase impressive operational execution and financial discipline. The 4% revenue growth to $3.0 billion for Q4 and $9.9 billion for FY2024 reflects robust organic growth of 5% across both periods. The standout metric is the dramatic improvement in Q4 operating margin to 29.7%, up 300 basis points year-over-year.

Segment performance reveals important insights: Health, Wealth & Career (HWC) achieved 3% organic growth with improved margins of 41.9%, while Risk & Broking (R&B) delivered stronger 7% organic growth with margins expanding to 33.5%. This balanced growth across segments demonstrates the success of WTW's transformation initiatives.

The company's cash flow metrics are particularly encouraging. Free cash flow increased by $184 million to $1.4 billion, supporting substantial shareholder returns through $901 million in share repurchases during 2024. The planned $1.5 billion in repurchases for 2025 signals management's confidence in future performance.

Looking ahead, WTW's outlook for 2025 includes several strategic shifts. The divestiture of TRANZACT, while resulting in a $1.0 billion impairment charge, streamlines the portfolio. The commitment to ~100 basis points of annual margin expansion in R&B over the next three years suggests continued focus on operational efficiency.

The transformation program's conclusion sets the stage for a new phase of growth, with emphasis on portfolio optimization and efficiency enhancement. While foreign currency headwinds and reinsurance joint venture impacts present near-term challenges, the underlying business momentum and strong cash generation capability position WTW favorably for sustained value creation.

WTW's Q4 performance demonstrates market leadership and strategic execution excellence. The 5% organic revenue growth is particularly impressive in the current market environment, reflecting strong client retention and new business acquisition. The margin expansion story is compelling, with adjusted operating margin reaching 36.1% in Q4, positioning WTW among the industry's top performers.

The company's segment-specific results reveal important market dynamics. HWC's growth in Global Benefits Management and LifeSight solutions indicates successful penetration of high-value markets. The R&B segment's performance, driven by new business activity and technology solutions, suggests strengthening competitive positioning in core markets.

Strategic portfolio refinement through the TRANZACT divestiture, while causing short-term earnings impact, aligns with industry trends toward higher-margin, more predictable revenue streams. The planned margin expansion in R&B signals potential market share gains in key segments.

The robust free cash flow generation and aggressive share repurchase program demonstrate financial strength and market confidence. These factors, combined with the successful transformation program completion, position WTW to capitalize on market opportunities and potentially expand its industry leadership position in 2025 and beyond.

02/04/2025 - 06:05 AM

Revenue¹ increased 4% over prior year to $3.0 billion for the quarter and increased 5% to $9.9 billion for the year
Organic Revenue growth of 5% for both the quarter and the year
Diluted Earnings per Share was $12.25 for the quarter, up 105% over prior year, and Diluted Loss² was $0.96 for the year.
Adjusted Diluted Earnings per Share was $8.13 for the quarter, up 9% from prior year, and $16.93 for the year, up 17% over prior year
Operating Margin was 29.7% for the quarter, up 300 basis points over prior year, and 6.3% for the year, down 810 basis points from prior year
Adjusted Operating Margin was 36.1% for the quarter, up 190 basis points from prior year, and 23.9% for the year, up 190 basis points over prior year

LONDON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW) (the “Company”), a leading global advisory, broking and solutions company, today announced financial results for the fourth quarter ended December 31, 2024.

“WTW is entering 2025 with considerable momentum after delivering on our 2024 financial targets through solid revenue growth, robust margin expansion and earnings growth,” said Carl Hess, WTW’s chief executive officer. “The successful completion of our Grow, Simplify and Transform strategy has primed all of our businesses to perform, and we are now stronger, more connected and more efficient than we have ever been. I’m confident our new strategy to accelerate our performance, enhance our efficiency and optimize our portfolio will produce innovative solutions for our customers and create more value for shareholders. I’m proud of our team’s dedication and look forward to executing on our strategic and financial goals in the years ahead.”

Consolidated Results

Fourth Quarter 2024, as reported, USD millions, except %

Key Metrics	Q4-24	Q4-23	Y/Y Change
Revenue¹	$3,035	$2,914	Reported 4% \| CC 5% \| Organic 5%
Income from Operations	$901	$779	16%
Operating Margin %	29.7%	26.7%	300 bps
Adjusted Operating Income	$1,096	$998	10%
Adjusted Operating Margin %	36.1%	34.2%	190 bps
Net Income	$1,248	$623	100%
Adjusted Net Income	$827	$775	7%
Diluted EPS	$12.25	$5.97	105%
Adjusted Diluted EPS	$8.13	$7.44	9%

Revenue was $3.04 billion for the fourth quarter of 2024, an increase of 4% as compared to $2.91 billion for the same period in the prior year. Excluding the impact of foreign currency, revenue increased 5%. On an organic basis, revenue increased 5%. See Supplemental Segment Information for additional detail on book-of-business settlements and interest income included in revenue.

Net Income for the fourth quarter of 2024 was $1.25 billion compared to Net Income of $623 million in the prior-year fourth quarter. Adjusted EBITDA for the fourth quarter was $1.2 billion, or 38.6% of revenue, an increase of 9%, compared to Adjusted EBITDA of $1.1 billion, or 37.1% of revenue, in the prior-year fourth quarter. The U.S. GAAP tax rate for the fourth quarter was 26.0%, and the adjusted income tax rate for the fourth quarter used in calculating adjusted diluted earnings per share was 21.3%.

Full Year 2024, as reported, USD millions, except %

Key Metrics	FY-24	FY-23	Y/Y Change
Revenue¹	$9,930	$9,483	Reported 5% \| CC 5% \| Organic 5%
Income from Operations	$627	$1,365	(54)%
Operating Margin %	6.3%	14.4%	(810) bps
Adjusted Operating Income	$2,378	$2,082	14%
Adjusted Operating Margin %	23.9%	22.0%	190 bps
Net (Loss)/Income²	$(88)	$1,064	NM
Adjusted Net Income	$1,730	$1,536	13%
Diluted EPS²	$(0.96)	$9.95	NM
Adjusted Diluted EPS	$16.93	$14.49	17%

¹	The revenue amounts included in this release are presented on a U.S. GAAP basis except where stated otherwise. This excludes reinsurance revenue which is reported in discontinued operations. The segment discussion is on an organic basis.
²	Net Loss and Diluted Loss Per Share for the year ended 2024 primarily includes impairment charges of over $1.0 billion related to the sale of TRANZACT.
^NM	Not meaningful

Revenue was $9.93 billion for the year ended December 31, 2024, an increase of 5% as compared to $9.48 billion for the prior year. On an organic basis, revenue increased 5%. See Supplemental Segment Information for additional detail on book-of-business settlements and interest income included in revenue.

Net Loss for the year ended December 31, 2024 was $88 million, compared to Net Income of $1.1 billion in the prior year. Adjusted EBITDA for 2024 was $2.7 billion, or 27.3% of revenue, an increase of $278 million, compared to Adjusted EBITDA of $2.4 billion, or 25.6% of revenue, in the prior year.

The U.S. GAAP tax rate for 2024 was 184.7%, and the adjusted income tax rate for 2024 used in calculating adjusted diluted earnings per share was 21.5%.

Cash Flow and Capital Allocation

Cash flows from operating activities were $1.5 billion for the year ended December 31, 2024, compared to $1.3 billion for the prior year. Free cash flow for the years ended December 31, 2024 and 2023 was $1.4 billion and $1.2 billion, respectively, an increase of $184 million, primarily driven by operating margin expansion, partially offset by cash outflows related to transformation and discretionary compensation payments. During the fourth quarter and year ended December 31, 2024, the Company repurchased $395 million and $901 million of WTW shares, respectively.

Fourth Quarter 2024 Segment Highlights

Health, Wealth & Career ("HWC")

As reported, USD millions, except %

Health, Wealth & Career	Q4-24	Q4-23	Y/Y Change
Total Revenue	$1,853	$1,798	Reported 3% \| CC 3% \| Organic 3%
Operating Income	$776	$729	6%
Operating Margin %	41.9%	40.5%	140 bps

The HWC segment had revenue of $1.85 billion in the fourth quarter of 2024, an increase of 3% (3% increase constant currency and organic) from $1.80 billion in the prior year. Health had organic revenue growth led by increased project work and brokerage income in North America and the continued expansion of our Global Benefits Management client portfolio in International and Europe. Wealth generated organic revenue growth from higher levels of Retirement work globally, an increase in our Investments business due to growth of our LifeSight solution and capital market improvements. Career had organic revenue growth from increased advisory services and product revenue. Benefits Delivery & Outsourcing (BD&O) had an organic revenue decline for the quarter primarily as a result of deliberately moderating growth in TRANZACT.

Operating margins in the HWC segment increased 140 basis points from the prior-year fourth quarter to 41.9%, primarily from Transformation savings. Please refer to the Supplemental Slides for TRANZACT's standalone historical financial results.

Risk & Broking ("R&B")

As reported, USD millions, except %

Risk & Broking	Q4-24	Q4-23	Y/Y Change
Total Revenue	$1,141	$1,076	Reported 6% \| CC 7% \| Organic 7%
Operating Income	$383	$354	8%
Operating Margin %	33.5%	32.9%	60 bps

The R&B segment had revenue of $1.14 billion in the fourth quarter of 2024, an increase of 6% (7% increase constant currency and organic) from $1.08 billion in the prior year. Corporate Risk & Broking (CRB) had organic revenue growth driven by higher levels of new business activity and strong client retention. Insurance Consulting and Technology (ICT) had organic revenue growth for the quarter primarily due to strong software sales in Technology.

Operating margins in the R&B segment increased 60 basis points from the prior-year fourth quarter to 33.5%, primarily due to operating leverage driven by organic revenue growth and disciplined expense management, as well as Transformation savings which were partially offset by headwinds from book-of-business activity and foreign currency fluctuations.

Select 2025 Financial Considerations

Changes to Non-GAAP financial measures:

All reported non-GAAP metrics will exclude non-cash net periodic pension and postretirement benefit credits
Free cash flow and free cash flow margin will capture cash outflows for capitalized software costs
Refer to Supplemental Slides for recast of historical Non-GAAP measures

Business mix:

Divested TRANZACT business, which contributed $1.14 to adjusted diluted earnings per share in 2024, is no longer part of the business portfolio
Reinsurance joint venture expected to be a headwind on adjusted diluted earnings per share of approximately $0.25 to $0.35

Free cash flow:

Expect cash outflows in 2025 from the settlement of accrued costs related to the Transformation program which concluded in 2024
Cash taxes related to receipt of earnout from reinsurance divestiture will be classified as Cash Flows from Operating Activities on Statement of Cash Flows

Capital allocation:

Expect share repurchases of ~$1.5 billion, subject to market conditions and potential capital allocation to organic and inorganic investment opportunities

Foreign exchange:

Expect a foreign currency headwind on adjusted diluted earnings per share of approximately $0.18 in 2025 at today's rates

Adjusted operating margin outlook:

~100 basis points of average annual margin expansion over next 3 years in R&B
Incremental annual margin expansion at HWC and enterprise levels

The 2025 Financial Considerations above include Non-GAAP financial measures. We do not reconcile forward-looking Non-GAAP measures for reasons explained under "WTW Non-GAAP Measures" below.

Conference Call

The Company will host a live webcast and conference call to discuss the financial results for the fourth quarter 2024. It will be held on Tuesday, February 4, 2025, beginning at 9:00 a.m. Eastern Time. A live broadcast of the conference call will be available on WTW’s website here. The conference call will include a question-and-answer session. To participate in the question-and-answer session, please register here. An online replay will be available at www.wtwco.com shortly after the call concludes.

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you. Learn more at www.wtwco.com.

WTW Non-GAAP Measures

In order to assist readers of our consolidated financial statements in understanding the core operating results that WTW’s management uses to evaluate the business and for financial planning, we present the following non-GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted Operating Income/Margin, (4) Adjusted EBITDA/Margin, (5) Adjusted Net Income, (6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before Taxes, (8) Adjusted Income Taxes/Tax Rate, (9) Free Cash Flow and (10) Free Cash Flow Margin.

We believe that those measures are relevant and provide pertinent information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating performance, and in the case of free cash flow, our liquidity results.

Within the measures referred to as ‘adjusted’, we adjust for significant items which will not be settled in cash, or which we believe to be items that are not core to our current or future operations. Some of these items may not be applicable for the current quarter, however they may be part of our full-year results. Additionally, we have historically adjusted for certain items which are not described below, but for which we may adjust in a future period when applicable. Items applicable to the quarter or full year results, or the comparable periods, include the following:

Restructuring costs and transaction and transformation – Management believes it is appropriate to adjust for restructuring costs and transaction and transformation when they relate to a specific significant program with a defined set of activities and costs that are not expected to continue beyond a defined period of time, or significant acquisition-related transaction expenses. We believe the adjustment is necessary to present how the Company is performing, both now and in the future when the incurrence of these costs will have concluded.
Impairment – Adjustment to remove the non-cash goodwill impairment associated with our Benefits, Delivery and Administration reporting unit related to the sale of our TRANZACT business.
Provisions for specified litigation matters – We will include provisions for litigation matters which we believe are not representative of our core business operations. Among other things, we determine this by reference to the amount of the loss (net of insurance and other recovery receivables) and by reference to whether the matter relates to an unusual and complex scenario that is not expected to be repeated as part of our ongoing, ordinary business. These amounts are presented net of insurance and other recovery receivables. See the footnotes to the respective reconciliation tables below for more specificity on the litigation matter excluded from adjusted results.
Gains and losses on disposals of operations – Adjustment to remove the gains or losses resulting from disposed operations that have not been classified as discontinued operations.
Pension settlement – Adjustment to remove significant pension settlement to better present how the Company is performing.
Tax effect of significant adjustments – Relates to the incremental tax expense or benefit resulting from significant or unusual events including significant statutory tax rate changes enacted in material jurisdictions in which we operate, internal reorganizations of ownership of certain businesses that reduced the investment held by our U.S.-controlled subsidiaries and the recovery of certain refunds or payment of taxes related to businesses in which we no longer participate.

We evaluate our revenue on an as reported (U.S. GAAP), constant currency and organic basis. We believe presenting constant currency and organic information provides valuable supplemental information regarding our comparable results, consistent with how we evaluate our performance internally.

We consider Constant Currency Change, Organic Change, Adjusted Operating Income/Margin, Adjusted EBITDA/Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Adjusted Income Before Taxes, Adjusted Income Taxes/Tax Rate and Free Cash Flow to be important financial measures, which are used to internally evaluate and assess our core operations and to benchmark our operating and liquidity results against our competitors. These non-GAAP measures are important in illustrating what our comparable operating and liquidity results would have been had we not incurred transaction-related and non-recurring items. Reconciliations of these measures are included in the accompanying tables with the following exception: The Company does not reconcile its forward-looking non-GAAP financial measures to the corresponding U.S. GAAP measures, due to variability and difficulty in making accurate forecasts and projections and/or certain information not being ascertainable or accessible; and because not all of the information, such as foreign currency impacts necessary for a quantitative reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure, is available to the Company without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The Company provides non-GAAP financial measures that it believes will be achieved, however it cannot accurately predict all of the components of the adjusted calculations and the U.S. GAAP measures may be materially different than the non-GAAP measures.

Our non-GAAP measures and their accompanying definitions are presented as follows:

Constant Currency Change – Represents the year-over-year change in revenue excluding the impact of foreign currency fluctuations. To calculate this impact, the prior year local currency results are first translated using the current year monthly average exchange rates. The change is calculated by comparing the prior year revenue, translated at the current year monthly average exchange rates, to the current year as reported revenue, for the same period. We believe constant currency measures provide useful information to investors because they provide transparency to performance by excluding the effects that foreign currency exchange rate fluctuations have on period-over-period comparability given volatility in foreign currency exchange markets.

Organic Change – Excludes the impact of fluctuations in foreign currency exchange rates, as described above and the period-over-period impact of acquisitions and divestitures on current-year revenue. We believe that excluding transaction-related items from our U.S. GAAP financial measures provides useful supplemental information to our investors, and it is important in illustrating what our core operating results would have been had we not included these transaction-related items, since the nature, size and number of these transaction-related items can vary from period to period.

Adjusted Operating Income/Margin – (Loss)/Income from operations adjusted for impairment, amortization, restructuring costs, transaction and transformation and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted operating income margin is calculated by dividing adjusted operating income by revenue. We consider adjusted operating income/margin to be important financial measures, which are used internally to evaluate and assess our core operations and to benchmark our operating results against our competitors.

Adjusted EBITDA/Margin – Net (Loss)/Income adjusted for provision for income taxes, interest expense, impairment, depreciation and amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted EBITDA Margin is calculated by dividing adjusted EBITDA by revenue. We consider adjusted EBITDA/margin to be important financial measures, which are used internally to evaluate and assess our core operations, to benchmark our operating results against our competitors and to evaluate and measure our performance-based compensation plans.

Adjusted Net Income – Net (Loss)/Income Attributable to WTW adjusted for impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results and the related tax effect of those adjustments and the tax effects of internal reorganizations. This measure is used solely for the purpose of calculating adjusted diluted earnings per share.

Adjusted Diluted Earnings Per Share – Adjusted Net Income divided by the weighted-average number of ordinary shares, diluted. Adjusted diluted earnings per share is used to internally evaluate and assess our core operations and to benchmark our operating results against our competitors.

Adjusted Income Before Taxes – (Loss)/Income from operations before income taxes adjusted for impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results. Adjusted income before taxes is used solely for the purpose of calculating the adjusted income tax rate.

Adjusted Income Taxes/Tax Rate – Benefit from/(provision for) income taxes adjusted for taxes on certain items of impairment, amortization, restructuring costs, transaction and transformation, gains and losses on disposals of operations, the tax effects of internal reorganizations, and non-recurring items that, in management’s judgment, significantly affect the period-over-period assessment of operating results, divided by adjusted income before taxes. Adjusted income taxes is used solely for the purpose of calculating the adjusted income tax rate. Management believes that the adjusted income tax rate presents a rate that is more closely aligned to the rate that we would incur if not for the reduction of pre-tax income for the adjusted items and the tax effects of internal reorganizations, which are not core to our current and future operations.

Free Cash Flow – Cash flows from operating activities less cash used to purchase fixed assets and software for internal use. Free Cash Flow is a liquidity measure and is not meant to represent residual cash flow available for discretionary expenditures. Management believes that free cash flow presents the core operating performance and cash-generating capabilities of our business operations.

Free Cash Flow Margin – Free Cash Flow as a percentage of revenue, which represents how much of revenue would be realized on a cash basis. We consider this measure to be a meaningful metric for tracking cash conversion on a year-over-year basis due to the non-cash nature of our pension income, which is included in our GAAP and Non-GAAP earnings metrics presented herein.

These non-GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measures of other companies. Non-GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our condensed consolidated financial statements.

WTW Forward-Looking Statements

This document contains ‘forward-looking statements’ within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. These forward-looking statements include information about possible or assumed future results of our operations or certain considerations relating to our future results. All statements, other than statements of historical facts, that address activities, events, or developments that we expect or anticipate may occur in the future, including such things as our outlook, plans and references to future performance, including our future financial and operating results (including our revenue, costs, or margins), short-term and long-term financial goals, plans, objectives, expectations and intentions, including with respect to organic revenue growth, free cash flow generation, adjusted net revenue, adjusted operating margin and adjusted earnings per share; future share repurchases; demand for our services and competitive strengths; strategic goals; existing and evolving business strategies including those related to acquisition and disposition activity; the benefits of new initiatives; the growth of our business and operations; the sustained health of our product, service, transaction, client, and talent assessment and management pipelines; our ability to successfully manage ongoing leadership, organizational, and technology changes, including investments in improving systems and processes; our ability to implement and realize anticipated benefits of any cost-savings initiatives including our multi-year operational transformation program; the potential impact of natural or man-made disasters like health pandemics and other world health crises; future capital expenditures; ongoing working capital efforts; the impact of changes to tax laws on our financial results; and our recognition of future impairment charges or write-off of receivables, are forward-looking statements. Also, when we use words such as ‘may’, ‘will’, ‘would’, ‘anticipate’, ‘believe’, ‘estimate’, ‘expect’, ‘intend’, ‘plan’, ‘continues’, ‘seek’, ‘target’, ‘goal’, ‘focus’, ‘probably’, or similar expressions, we are making forward-looking statements. Such statements are based upon the current beliefs and expectations of our management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. All forward-looking disclosure is speculative by its nature.

There are important risks, uncertainties, events and factors that could cause our actual results or performance to differ materially from those in the forward-looking statements contained in this document, including the following: our ability to successfully establish, execute and achieve our global business strategy as it evolves; our ability to fully realize the anticipated benefits of our growth strategy, including inorganic growth through acquisitions; our ability to execute strategic transactions, including both acquisitions and dispositions, including our ability to receive adequate consideration or any earnout proceeds in return for any dispositions or integrate or manage acquired businesses or effect internal reorganizations; incremental risks relating to the transitional arrangements in effect subsequent to our previously completed sale of TRANZACT; our ability to successfully manage ongoing organizational changes, investments in improving systems and processes, and in connection with our acquisition and divestiture activities; risks relating to changes in our management structures and in senior leadership; our ability to achieve our short-term and long-term financial goals, such as with respect to our cash flow generation, and the timing with respect to such achievement; the risks related to changes in general economic conditions, business and political conditions, changes in the financial markets, inflation, credit availability, increased interest rates and changes in trade policies; the risks to our short-term and long-term financial goals from any of the risks or uncertainties set forth herein; the risks relating to the adverse impacts of macroeconomic trends, including inflation, changes in interest rates and trade policies, as well as political events, war, such as the Russia-Ukraine and Middle East conflicts, and other international disputes, terrorism, natural disasters, public health issues and other business interruptions on the global economy and capital markets, which could have a material adverse effect on our business, financial condition, results of operations, and long-term goals; our ability to successfully hedge against fluctuations in foreign currency rates; the risks relating to the adverse impacts of natural or man-made disasters such as health pandemics and other world health crises on the demand for our products and services, our cash flows and our business operations; material interruptions to or loss of our information processing capabilities, or failure to effectively maintain and upgrade our information technology resources and systems and related risks of cybersecurity breaches or incidents; our ability to comply with complex and evolving regulations related to data privacy, cybersecurity, and artificial intelligence; significant competition that we face and the potential for loss of market share and/or profitability; the impact of seasonality and differences in timing of renewals and non-recurring revenue increases from disposals and book-of-business sales; the insufficiency of client data protection, potential breaches of information systems or insufficient safeguards against cybersecurity breaches or incidents; the risk of increased liability or new legal claims arising from our new and existing products and services, and expectations, intentions and outcomes relating to outstanding litigation; the risk of substantial negative outcomes on existing litigation or investigation matters; changes in the regulatory environment in which we operate, including, among other risks, the impacts of pending competition law and regulatory investigations; various claims, government inquiries or investigations or the potential for regulatory action; our ability to integrate direct-to-consumer sales and marketing solutions with our existing offerings and solutions; disasters or business continuity problems; our ability to successfully enhance our billing, collection and other working capital efforts, and thereby increase our free cash flow; our ability to properly identify and manage conflicts of interest; reputational damage, including from association with third parties; reliance on third-party service providers and suppliers; the loss of key employees or a large number of employees and rehiring rates; our ability to maintain our corporate culture; doing business internationally, including the impact of foreign currency exchange rates; compliance with extensive government regulation; the risk of sanctions imposed by governments, or changes to associated sanction regulations (such as sanctions imposed on Russia) and related counter-sanctions; our ability to effectively apply technology, data and analytics changes for internal operations, maintaining industry standards and meeting client preferences; changes and developments in the insurance industry or the U.S. healthcare system, including those related to Medicare, any legislative actions from the current U.S. Congress, the recent Final Rule from the Centers for Medicare & Medicaid Services for contract year 2025 and any judicial claims, rulings and appeals related thereto, and any other changes and developments in legal, regulatory, economic, business or operational conditions that could impact our Medicare benefits businesses; the inability to protect our intellectual property rights, or the potential infringement upon the intellectual property rights of others; fluctuations in our pension assets and liabilities and related changes in pension income, including as a result of, related to, or derived from movements in the interest rate environment, investment returns, inflation, or changes in other assumptions that are used to estimate our benefit obligations and their effect on adjusted earnings per share; our capital structure, including indebtedness amounts, the limitations imposed by the covenants in the documents governing such indebtedness and the maintenance of the financial and disclosure controls and procedures of each; our ability to obtain financing on favorable terms or at all; adverse changes in our credit ratings; the impact of recent or potential changes to U.S. or foreign laws, and the enactment of additional, or the revision of existing, state, federal, and/or foreign laws and regulations, recent judicial decisions and development of case law, other regulations and any policy changes and legislative actions, including those that may impose additional excise taxes or impact our effective tax rate; U.S. federal income tax consequences to U.S. persons owning at least 10% of our shares; changes in accounting principles, estimates or assumptions; our recognition of future non-cash pre-tax losses and related impairment charges; risks relating to or arising from environmental, social and governance practices; fluctuation in revenue against our relatively fixed or higher than expected expenses; the laws of Ireland being different from the laws of the U.S. and potentially affording less protections to the holders of our securities; and our holding company structure potentially preventing us from being able to receive dividends or other distributions in needed amounts from our subsidiaries.

The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results. For more information, please see Part I, Item 1A in our Annual Report on Form 10-K, and our subsequent filings with the SEC. Copies are available online at www.sec.gov or www.wtwco.com.

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and therefore also the forward-looking statements based on these assumptions, could themselves prove to be inaccurate. Given the significant uncertainties inherent in the forward-looking statements included in this document, our inclusion of this information is not a representation or guarantee by us that our objectives and plans will be achieved.

Our forward-looking statements speak only as of the date made, and we will not update these forward-looking statements unless the securities laws require us to do so. With regard to these risks, uncertainties and assumptions, the forward-looking events discussed in this document may not occur, and we caution you against unduly relying on these forward-looking statements.

Contact

INVESTORS
Claudia De La Hoz | Claudia.Delahoz@wtwco.com

WTW Supplemental Segment Information (In millions of U.S. dollars) (Unaudited)

REVENUE
						Components of Revenue Change⁽ⁱ⁾
						Less:		Less:
	Three Months Ended December 31,				As Reported	Currency	Constant Currency	Acquisitions/	Organic
	2024		2023		% Change	Impact	Change	Divestitures	Change

Health, Wealth & Career
Revenue excluding interest income	$	1,847	$	1,791	3%	0%	3%	0%	3%
Interest income		6		7
Total		1,853		1,798	3%	0%	3%	0%	3%

Risk & Broking
Revenue excluding interest income	$	1,115	$	1,049	6%	(1)%	7%	0%	7%
Interest income		26		27
Total		1,141		1,076	6%	(1)%	7%	0%	7%

Segment Revenue	$	2,994	$	2,874	4%	(1)%	5%	0%	5%
Corporate, reimbursable expenses and other		37		35
Interest income		4		5
Revenue	$	3,035	$	2,914	4%	(1)%	5%	0%	5%⁽ⁱⁱ⁾

						Components of Revenue Change⁽ⁱ⁾
						Less:		Less:
	Years Ended December 31,				As Reported	Currency	Constant Currency	Acquisitions/	Organic
	2024		2023		% Change	Impact	Change	Divestitures	Change

Health, Wealth & Career
Revenue excluding interest income	$	5,745	$	5,557	3%	0%	3%	0%	4%
Interest income		32		25
Total		5,777		5,582	3%	0%	4%	0%	4%

Risk & Broking
Revenue excluding interest income	$	3,926	$	3,656	7%	0%	8%	0%	8%
Interest income		112		79
Total		4,038		3,735	8%	(1)%	9%	0%	8%

Segment Revenue	$	9,815	$	9,317	5%	0%	6%	0%	6%
Corporate, reimbursable expenses and other		93		125
Interest income		22		41
Revenue	$	9,930	$	9,483	5%	0%	5%	0%	5%⁽ⁱⁱ⁾

⁽ⁱ⁾ Components of revenue change may not add due to rounding.
⁽ⁱⁱ⁾ Interest income did not contribute to organic change for the three months and year ended December 31, 2024.

BOOK-OF-BUSINESS SETTLEMENTS AND INTEREST INCOME

	Three Months Ended December 31,
	HWC				R&B				Corporate				Total
	2024		2023		2024		2023		2024		2023		2024		2023
Book-of-business settlements	$	5	$	1	$	6	$	14	$	—	$	—	$	11	$	15
Interest income		6		7		26		27		4		5		36		39
Total	$	11	$	8	$	32	$	41	$	4	$	5	$	47	$	54

	Years Ended December 31,
	HWC				R&B				Corporate				Total
	2024		2023		2024		2023		2024		2023		2024		2023
Book-of-business settlements	$	8	$	1	$	14	$	25	$	—	$	—	$	22	$	26
Interest income		32		25		112		79		22		41		166		145
Total	$	40	$	26	$	126	$	104	$	22	$	41	$	188	$	171

SEGMENT OPERATING INCOME⁽ⁱ⁾

	Three Months Ended December 31,
	2024		2023

Health, Wealth & Career	$	776	$	729
Risk & Broking		383		354
Segment Operating Income	$	1,159	$	1,083

	Years Ended December 31,
	2024		2023

Health, Wealth & Career	$	1,717	$	1,565
Risk & Broking		958		813
Segment Operating Income	$	2,675	$	2,378

⁽ⁱ⁾Segment operating income excludes certain costs, including amortization of intangibles, restructuring costs, transaction and transformation expenses, certain litigation provisions, and to the extent that the actual expense based upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally-allocated expenses and the actual expenses reported for U.S. GAAP purposes.

SEGMENT OPERATING MARGINS

	Three Months Ended December 31,
	2024	2023
Health, Wealth & Career	41.9%	40.5%
Risk & Broking	33.5%	32.9%

	Years Ended December 31,
	2024	2023
Health, Wealth & Career	29.7%	28.0%
Risk & Broking	23.7%	21.8%

RECONCILIATIONS OF SEGMENT OPERATING INCOME TO INCOME FROM OPERATIONS BEFORE INCOME TAXES

	Three Months Ended December 31,
	2024			2023

Segment Operating Income	$	1,159		$	1,083
Amortization		(50	)		(60	)
Restructuring costs		(32	)		(38	)
Transaction and transformation⁽ⁱ⁾		(113	)		(121	)
Unallocated, net⁽ⁱⁱ⁾		(63	)		(85	)
Income from Operations		901			779
Interest expense		(66	)		(63	)
Other income, net		853			23
Income from operations before income taxes	$	1,688		$	739

	Years Ended December 31,
	2024			2023

Segment Operating Income	$	2,675		$	2,378
Impairment⁽ⁱⁱⁱ⁾		(1,042	)		—
Amortization		(226	)		(263	)
Restructuring costs		(61	)		(68	)
Transaction and transformation⁽ⁱ⁾		(409	)		(386	)
Unallocated, net⁽ⁱⁱ⁾		(310	)		(296	)
Income from Operations		627			1,365
Interest expense		(263	)		(235	)
Other (loss)/income, net		(260	)		149
Income from operations before income taxes	$	104		$	1,279

⁽ⁱ⁾In 2024 and 2023, in addition to legal fees and other transaction costs, includes primarily consulting fees and compensation costs related to the Transformation program.
⁽ⁱⁱ⁾Includes certain costs, primarily related to corporate functions which are not directly related to the segments, and certain differences between budgeted expenses determined at the beginning of the year and actual expenses that we report for U.S. GAAP purposes.
⁽ⁱⁱⁱ⁾Represents the non-cash goodwill impairment associated with our BDA reporting unit related to the completed sale of our TRANZACT business.

WTW
Reconciliations of Non-GAAP Measures
(In millions of U.S. dollars, except per share data)
(Unaudited)

RECONCILIATIONS OF NET INCOME/(LOSS) ATTRIBUTABLE TO WTW TO ADJUSTED DILUTED EARNINGS PER SHARE

	Three Months Ended December 31,
	2024			2023

Net income attributable to WTW	$	1,246		$	622
Adjusted for certain items:
Amortization		50			60
Restructuring costs		32			38
Transaction and transformation		113			121
Pension settlement		23			—
(Gain)/loss on disposal of operations		(853	)		1
Tax effect on certain items listed above⁽ⁱ⁾		216			(67	)
Adjusted Net Income	$	827		$	775

Weighted-average ordinary shares, diluted		102			104

Diluted Earnings Per Share	$	12.25		$	5.97
Adjusted for certain items:⁽ⁱⁱ⁾
Amortization		0.49			0.58
Restructuring costs		0.31			0.36
Transaction and transformation		1.11			1.16
Pension settlement		0.23			—
(Gain)/loss on disposal of operations		(8.39	)		0.01
Tax effect on certain items listed above⁽ⁱ⁾		2.12			(0.64	)
Adjusted Diluted Earnings Per Share⁽ⁱⁱ⁾	$	8.13		$	7.44

	Years Ended December 31,
	2024			2023

Net (loss)/income attributable to WTW	$	(98	)	$	1,055
Adjusted for certain items:
Impairment		1,042			—
Amortization		226			263
Restructuring costs		61			68
Transaction and transformation		409			386
Provision for specified litigation matter⁽ⁱⁱⁱ⁾		13			—
Pension settlement		23			—
Loss/(gain) on disposal of operations		337			(43	)
Tax effect on certain items listed above⁽ⁱ⁾		(276	)		(195	)
Tax effect of significant adjustments		(7	)		2
Adjusted Net Income	$	1,730		$	1,536

Weighted-average ordinary shares, diluted^(iv)		102			106

Diluted (Loss)/Earnings Per Share^(iv)	$	(0.96	)	$	9.95
Adjusted for certain items:⁽ⁱⁱ⁾
Impairment		10.20			—
Amortization		2.21			2.48
Restructuring costs		0.60			0.64
Transaction and transformation		4.00			3.64
Provision for specified litigation matter⁽ⁱⁱⁱ⁾		0.13			—
Pension settlement		0.23			—
Loss/(gain) on disposal of operations		3.30			(0.41	)
Tax effect on certain items listed above⁽ⁱ⁾		(2.70	)		(1.84	)
Tax effect of significant adjustments		(0.07	)		0.02
Adjusted Diluted Earnings Per Share⁽ⁱⁱ⁾	$	16.93		$	14.49

⁽ⁱ⁾The tax effect was calculated using an effective tax rate for each item.
⁽ⁱⁱ⁾ Per share values and totals may differ due to rounding.
⁽ⁱⁱⁱ⁾ Represents a provision related to litigation arising out of a structured insurance program originally placed for a client over 15 years ago. The program is of a type and complexity that was highly bespoke to the client and for that reason is unlikely to be exactly replicated elsewhere. We believe excluding this matter from adjusted results makes results more comparable from period to period and more representative of our core business operations.
^(iv) When there is a net loss attributable to WTW for the period, basic and diluted shares and earnings per share are the same values.

RECONCILIATIONS OF NET INCOME/(LOSS) TO ADJUSTED EBITDA

	Three Months Ended December 31,
	2024				2023

Net Income	$	1,248		41.1%	$	623	21.4%
Provision for income taxes		440				116
Interest expense		66				63
Depreciation		54				58
Amortization		50				60
Restructuring costs		32				38
Transaction and transformation		113				121
Pension settlement		23				—
(Gain)/loss on disposal of operations		(853	)			1
Adjusted EBITDA and Adjusted EBITDA Margin	$	1,173		38.6%	$	1,080	37.1%

	Years Ended December 31,
	2024				2023

Net (Loss)/Income	$	(88	)	(0.9)%	$	1,064		11.2%
Provision for income taxes		192				215
Interest expense		263				235
Impairment		1,042				—
Depreciation		230				242
Amortization		226				263
Restructuring costs		61				68
Transaction and transformation		409				386
Provision for specified litigation matter⁽ⁱ⁾		13				—
Pension settlement		23				—
Loss/(gain) on disposal of operations		337				(43	)
Adjusted EBITDA and Adjusted EBITDA Margin	$	2,708		27.3%	$	2,430		25.6%

⁽ⁱ⁾Represents a provision related to litigation arising out of a structured insurance program originally placed for a client over 15 years ago. The program is of a type and complexity that was highly bespoke to the client and for that reason is unlikely to be exactly replicated elsewhere. We believe excluding this matter from adjusted results makes results more comparable from period to period and more representative of our core business operations.

RECONCILIATIONS OF INCOME FROM OPERATIONS TO ADJUSTED OPERATING INCOME

	Three Months Ended December 31,
	2024			2023

Income from operations and Operating margin	$	901	29.7%	$	779	26.7%
Adjusted for certain items:
Amortization		50			60
Restructuring costs		32			38
Transaction and transformation		113			121
Adjusted operating income and Adjusted operating income margin	$	1,096	36.1%	$	998	34.2%

	Years Ended December 31,
	2024			2023

Income from operations and Operating margin	$	627	6.3%	$	1,365	14.4%
Adjusted for certain items:
Impairment		1,042			—
Amortization		226			263
Restructuring costs		61			68
Transaction and transformation		409			386
Provision for specified litigation matter⁽ⁱ⁾		13			—
Adjusted operating income and Adjusted operating income margin	$	2,378	23.9%	$	2,082	22.0%

RECONCILIATIONS OF GAAP INCOME TAXES/TAX RATE TO ADJUSTED INCOME TAXES/TAX RATE

	Three Months Ended December 31,
	2024			2023

Income from operations before income taxes	$	1,688		$	739

Adjusted for certain items:
Amortization		50			60
Restructuring costs		32			38
Transaction and transformation		113			121
Pension settlement		23			—
(Gain)/loss on disposal of operations		(853	)		1
Adjusted income before taxes	$	1,053		$	959

Provision for income taxes	$	440		$	116
Tax effect on certain items listed above⁽ⁱⁱ⁾		(216	)		67
Adjusted income taxes	$	224		$	183

U.S. GAAP tax rate		26.0	%		15.7	%
Adjusted income tax rate		21.3	%		19.1	%

	Years Ended December 31,
	2024			2023

Income from operations before income taxes	$	104		$	1,279

Adjusted for certain items:
Impairment		1,042			—
Amortization		226			263
Restructuring costs		61			68
Transaction and transformation		409			386
Provision for specified litigation matter⁽ⁱ⁾		13			—
Pension settlement		23			—
Loss/(gain) on disposal of operations		337			(43	)
Adjusted income before taxes	$	2,215		$	1,953

Provision for income taxes	$	192		$	215
Tax effect on certain items listed above⁽ⁱⁱ⁾		276			195
Tax effect of significant adjustments		7			(2	)
Adjusted income taxes	$	475		$	408

U.S. GAAP tax rate		184.7	%		16.8	%
Adjusted income tax rate		21.5	%		20.9	%

RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW

	Years Ended December 31,
	2024			2023

Cash flows from operating activities	$	1,512		$	1,345
Less: Additions to fixed assets and software for internal use		(136	)		(153	)
Free Cash Flow	$	1,376		$	1,192

Revenue	$	9,930		$	9,483
Free Cash Flow Margin		13.9	%		12.6	%

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY Condensed Consolidated Statements of Income (In millions of U.S. dollars, except per share data) (Unaudited)

	Three Months Ended December 31,						Years Ended December 31,
	2024			2023			2024			2023
Revenue	$	3,035		$	2,914		$	9,930		$	9,483

Costs of providing services
Salaries and benefits		1,367			1,325			5,502			5,344
Other operating expenses		518			533			1,833			1,815
Impairment		—			—			1,042			—
Depreciation		54			58			230			242
Amortization		50			60			226			263
Restructuring costs		32			38			61			68
Transaction and transformation		113			121			409			386
Total costs of providing services		2,134			2,135			9,303			8,118

Income from operations		901			779			627			1,365

Interest expense		(66	)		(63	)		(263	)		(235	)
Other income/(loss), net		853			23			(260	)		149

INCOME FROM OPERATIONS BEFORE INCOME TAXES		1,688			739			104			1,279

Provision for income taxes		(440	)		(116	)		(192	)		(215	)

NET INCOME/(LOSS)		1,248			623			(88	)		1,064

Income attributable to non-controlling interests		(2	)		(1	)		(10	)		(9	)

NET INCOME/(LOSS) ATTRIBUTABLE TO WTW	$	1,246		$	622		$	(98	)	$	1,055

EARNINGS/(LOSS) PER SHARE
Basic earnings/(loss) per share	$	12.32		$	6.02		$	(0.96	)	$	10.01
Diluted earnings/(loss) per share	$	12.25		$	5.97		$	(0.96	)	$	9.95

Weighted-average ordinary shares, basic		101			103			102			105
Weighted-average ordinary shares, diluted		102			104			102			106

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY Condensed Consolidated Balance Sheets (In millions of U.S. dollars, except share data) (Unaudited)

	December 31,			December 31,
	2024			2023
ASSETS
Cash and cash equivalents	$	1,890		$	1,424
Fiduciary assets		9,504			9,073
Accounts receivable, net		2,494			2,572
Prepaid and other current assets		1,217			364
Total current assets		15,105			13,433
Fixed assets, net		661			720
Goodwill		8,799			10,195
Other intangible assets, net		1,295			2,016
Right-of-use assets		485			565
Pension benefits assets		530			588
Other non-current assets		806			1,573
Total non-current assets		12,576			15,657
TOTAL ASSETS	$	27,681		$	29,090
LIABILITIES AND EQUITY
Fiduciary liabilities	$	9,504		$	9,073
Deferred revenue and accrued expenses		2,211			2,104
Current debt		—			650
Current lease liabilities		118			125
Other current liabilities		793			678
Total current liabilities		12,626			12,630
Long-term debt		5,309			4,567
Liability for pension benefits		615			563
Deferred tax liabilities		45			542
Provision for liabilities		341			365
Long-term lease liabilities		502			592
Other non-current liabilities		226			238
Total non-current liabilities		7,038			6,867
TOTAL LIABILITIES		19,664			19,497
COMMITMENTS AND CONTINGENCIES
EQUITY⁽ⁱ⁾
Additional paid-in capital		10,989			10,910
Retained earnings		109			1,466
Accumulated other comprehensive loss, net of tax		(3,158	)		(2,856	)
Total WTW shareholders' equity		7,940			9,520
Non-controlling interests		77			73
Total Equity		8,017			9,593
TOTAL LIABILITIES AND EQUITY	$	27,681		$	29,090

________________________
(i) Equity includes (a) Ordinary shares $0.000304635 nominal value; Authorized 1,510,003,775; Issued 99,805,780 (2024) and 102,538,072 (2023); Outstanding 99,805,780 (2024) and 102,538,072 (2023) and (b) Preference shares, $0.000115 nominal value; Authorized 1,000,000,000 and Issued none in 2024 and 2023.

WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY Condensed Consolidated Statements of Cash Flows (In millions of U.S. dollars) (Unaudited)

	Years Ended December 31,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES
NET (LOSS)/INCOME	$	(88	)	$	1,064
Adjustments to reconcile net income to total net cash from operating activities:
Depreciation		230			242
Amortization		226			263
Impairment		1,042			—
Non-cash restructuring charges		41			38
Non-cash lease expense		98			105
Net periodic benefit of defined benefit pension plans		4			(26	)
Provision for doubtful receivables from clients		13			6
Benefit from deferred income taxes		(213	)		(109	)
Share-based compensation		121			125
Net loss/(gain) on disposal of operations		337			(43	)
Non-cash foreign exchange (gain)/loss		(31	)		20
Other, net		58			31
Changes in operating assets and liabilities, net of effects from purchase of subsidiaries:
Accounts receivable		(233	)		(206	)
Other assets		(373	)		(185	)
Other liabilities		301			16
Provisions		(21	)		4
Net cash from operating activities		1,512			1,345

CASH FLOWS FROM/(USED IN) INVESTING ACTIVITIES
Additions to fixed assets and software for internal use		(136	)		(153	)
Capitalized software costs		(109	)		(89	)
Acquisitions of operations, net of cash acquired		(107	)		(6	)
Proceeds from sale of operations		619			89
Cash and fiduciary funds transferred in sale of operations		(5	)		(922	)
Purchase of investments		(12	)		(4	)
Net cash from/(used in) investing activities		250			(1,085	)

CASH FLOWS USED IN FINANCING ACTIVITIES
Senior notes issued		746			748
Debt issuance costs		(9	)		(7	)
Repayments of debt		(655	)		(254	)
Repurchase of shares		(901	)		(1,000	)
Net proceeds/(payments) from fiduciary funds held for clients		785			(234	)
Payments of deferred and contingent consideration related to acquisitions		(2	)		(12	)
Cash paid for employee taxes on withholding shares		(56	)		(26	)
Dividends paid		(354	)		(352	)
Acquisitions of and dividends paid to non-controlling interests		(13	)		(63	)
Net cash used in financing activities		(459	)		(1,200	)

INCREASE/(DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		1,303			(940	)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(97	)		11
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD ⁽ⁱ⁾		3,792			4,721
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD ⁽ⁱ⁾	$	4,998		$	3,792

________________________
(i) The amounts of cash, cash equivalents and restricted cash, their respective classification on the condensed consolidated balance sheets, as well as their respective portions of the increase or decrease in cash, cash equivalents and restricted cash for each of the periods presented have been included in the Supplemental Disclosures of Cash Flow Information section.

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

	Years Ended December 31,
	2024		2023

Supplemental disclosures of cash flow information:
Cash and cash equivalents	$	1,890	$	1,424
Fiduciary funds (included in fiduciary assets)		3,108		2,368
Total cash, cash equivalents and restricted cash	$	4,998	$	3,792

Increase/(decrease) in cash, cash equivalents and other restricted cash	$	510	$	163
Increase/(decrease) in fiduciary funds		793		(1,103	)
Total ⁽ⁱ⁾	$	1,303	$	(940	)

⁽ⁱ⁾Does not include the effect of exchange rate changes on cash, cash equivalents and restricted cash.

FAQ

What were WTW's Q4 2024 revenue and earnings results?

WTW reported Q4 2024 revenue of $3.0 billion, up 4% year-over-year, with diluted EPS of $12.25 (up 105%) and adjusted diluted EPS of $8.13 (up 9%).

How much did WTW spend on share repurchases in 2024?

WTW repurchased $901 million of shares during 2024, with $395 million of that occurring in the fourth quarter.

What caused WTW's full-year 2024 net loss?

WTW reported a full-year net loss of $88 million primarily due to impairment charges of over $1.0 billion related to the sale of TRANZACT.

What was WTW's organic revenue growth in Q4 2024?

WTW achieved 5% organic revenue growth in Q4 2024, consistent with their full-year organic growth rate.

How did WTW's operating margin perform in Q4 2024?

WTW's Q4 2024 operating margin improved to 29.7%, up 300 basis points from the prior year.

WTW Reports Fourth Quarter and Full Year 2024 Earnings

Insights

FAQ

What were WTW's Q4 2024 revenue and earnings results?

How much did WTW spend on share repurchases in 2024?

What caused WTW's full-year 2024 net loss?

What was WTW's organic revenue growth in Q4 2024?

How did WTW's operating margin perform in Q4 2024?

NASDAQ:WTW

WTW Rankings

WTW Latest News

WTW Stock Data

Trending News

WTW Reports Fourth Quarter and Full Year 2024 Earnings

Insights

Financial Analyst positive

Market Research Analyst positive

FAQ

What were WTW's Q4 2024 revenue and earnings results?

How much did WTW spend on share repurchases in 2024?

What caused WTW's full-year 2024 net loss?

What was WTW's organic revenue growth in Q4 2024?

How did WTW's operating margin perform in Q4 2024?

NASDAQ:WTW

WTW Rankings

WTW Latest News

WTW Stock Data